ERBB2 and breast cancer: In the survival analysis, the rate of colony formation in response to 3 Gy irradiation indicated that treatment with lapatinib or S3I-201, when combined with radiation, led to a significant reduction in the survival rate of HER2-positive SKBR3 breast cancer cells (Figure 4C).